Login

Healthcare

00:00:00
Akers Biosciences Inc to be cash generative in second half - Raymond Akers, Executive chairman of Akers Biosciences Inc
00:00:00
Alimera Sciences - RICK EISWIRTH President and Chief Executive Officer, Alimera Sciences Inc
00:00:00
Allergy Therapeutics to sniff out more M&A deals - Manuel Llobert, CEO, Allergy Therapeutics
00:00:00
Allergy Therapeutics says US preparations are underway which include two pivotal trials - Manuel Llobert, CEO, Allergy Therapeutics
00:00:00
Allergy Therapeutics - Nick Wykeman, CFO
00:00:00
Alligator Bioscience - CEO Statement - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Alligator Bioscience restructuring as part of long-term strategy - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Alligator meets primary endpoint with CD40 agonist in pancreatic cancer - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Alligator Bioscience at the ØU Lifescience Investor Conference, November 22, 2023 - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Alligator Bioscience | May 2023 - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
aims to be an innovative drug discovery and development company - Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc
00:00:00
Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc
00:00:00
Paul Grint Discusses AmpliPhi Biosciences - Paul Grint, CEO, AmpliPhi Biosciences Corp
00:00:00
Amryt Pharma hail rocketing revenue growth 'we're a biotech that makes money - Joe Wiley, CEO, Amryt Pharma
00:00:00
Anatara Lifesciences with Proactive at ASX Small and Mid-Cap Conference - Steve Lydeamore, CEO, Anatara Lifesciences Ltd
00:00:00
Anatara Lifesciences transitions gut health focus from animals to humans - Steve Lydeamore, CEO, Anatara Lifesciences Ltd

© 2017 - Townhall + Tv